Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This study tests an experimental injection called TQH2722 in 500 adults with moderate to severe atopic dermatitis (eczema). Half receive the drug, half a placebo, and neither they nor their doctors know which. The goal is to see if the drug safely reduces skin redness, itching, a…

This study tests an experimental drug called TQC2731 in 258 adults aged 40-80 with moderate to severe COPD. Participants receive either the drug or a placebo to see if it reduces the number of serious flare-ups over 24 weeks and improves breathing. The goal is to better control t…